Louisiana · 2026 Regular Session · Concurrent Resolution
SCR 22: PHARMACEUTICALS: Requests a legislative auditor report on opioid settlement fund expenditures.
Passed one chamber Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SCR 22 is a concurrent resolution introduced in the Louisiana Senate on March 30, 2026. According to its official title, it concerns: PHARMACEUTICALS: Requests a legislative auditor report on opioid settlement fund expenditures. Primary sponsor: Brach Myers (Republican). It lists 7 additional sponsors. Most recent recorded action (May 20, 2026): Sent to the Secretary of State by the Secretary of the Senate.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 5 · Republican 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Brach Myers | Primary sponsor | Republican | Senate | 23 |
| Regina Barrow | Co-sponsor | Democratic | Senate | 15 |
| Gerald Boudreaux | Co-sponsor | Democratic | Senate | 24 |
| Tehmi Chassion | Co-sponsor | Democratic | House | 44 |
| Katrina Jackson-Andrews | Co-sponsor | Democratic | Senate | 34 |
| Jay Luneau | Co-sponsor | Democratic | Senate | 29 |
| Thomas Pressly | Co-sponsor | Republican | Senate | 38 |
| Annie Spell | Co-sponsor | Republican | House | 45 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Sent to the Secretary of State by the Secretary of the Senate.
- Enrolled. Signed by the President of the Senate.
- Signed by the Speaker of the House.
- Amendments proposed by the House read and concurred in by a vote of 35 yeas and 0 nays.
- Read by title, amended, concurred in by vote of 81 yeas, 0 nays.
- Received from the House with amendments.
- Scheduled for floor debate on 05/13/2026.
- Read by title, passed to 3rd reading.
- Reported favorably (11-0).
- Read by title, under the rules, referred to the Committee on Health and Welfare.
- Read by title and adopted by a vote of 38 yeas and 0 nays. Ordered sent to the House.
- Received in the House from the Senate.
Showing 12 most recent of 16 actions. Full history